PRESS RELEASE (10/22/21) – Dr. David Berger to Present to FDA About Pfizer Vaccine and Children

Oct 22, 2021


Dr. David to Address FDA Vaccine Committee on Pfizer COVID Vaccine and Children Ages 5-11



Contact: Leslie Farrell, 813.493.1805

Dr. David Berger to Present to FDA: Pfizer Vaccine and Children 

Tampa, Fla. – Board certified pediatrician, Dr. David Berger, founder of Wholistic Pediatrics & Family Care and, will present his expert opinions to the U.S. Food and Drug Administration (FDA) about the efficacy of the Pfizer vaccine for children ages 5 – 11 on Tuesday, Oct. 26.  

If the FDA deems this vaccine safe and effective for younger children, Dr. Berger supports making it available so that parents have more choices in how they protect their children and families. 

Dr. Berger understands many parents are hesitant to vaccinate their children, and stresses the importance of listening to the reasons behind their hesitancy and providing accurate information. He calls for increased civility and respect for differing opinions, realizing that shunning parents will not alleviate their concerns. 

“No one benefits if we judge and ridicule each other,” says Dr. Berger. “Parents strive to make decisions they think are best for their children, and while many will get their children vaccinated right away, some will wait, or choose not to vaccinate at all.” 

In a letter to the FDA, Dr. Berger also highlighted the need for more data about the effects of the Pfizer vaccine on young children. Parents have expressed their concerns with the relatively low number of children included in the studies. 

“Assuming there was roughly an even number of children studied in each age group, this suggests less than 1,000 children in the five to seven-year-old range were studied. The same would be true for other age groups. I question if this is enough of a sample size to understand the incidence of myocarditis and other uncommon side effects,” Dr. Berger wrote, adding he would also like the Committee to address how much clinical relevance the vaccine has in terms of lowering the already low frequency of hospitalization and death, pediatric long-hauler symptoms, and family or community spread.

Dr. Berger will present to the committee between 1:00 to 2:00 p.m. EST on Tuesday, Oct. 26. The meeting can be viewed online at:

Dr Berger is available for interviews and has provided more information and educational videos on several topics, including COVID 19 and vaccines, at